Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Lipid metabolism4743 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A26090 | 21122807 | Toxicol Appl Pharmacol | Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment. | 2010 | Details |
A26093 | 21115542 | Gut | Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis. | 2010 | Details |
A26095 | 26190482 | Clin J Gastroenterol | The latest idea in NAFLD/NASH pathogenesis. | 2010 | Details |
A26109 | 21079772 | PLoS One | Changes in hepatic gene expression upon oral administration of taurine-conjugated ursodeoxycholic acid in ob/ob mice. | 2010 | Details |
A26112 | 21075404 | Metabolism | Lipid in the livers of adolescents with nonalcoholic steatohepatitis: combined effects of pathways on steatosis. | 2010 | Details |
A26128 | 21054517 | J Gastroenterol Hepatol | Sophocarpine alleviates non-alcoholic steatohepatitis in rats. | 2011 | Details |
A26133 | 21044016 | Curr Vasc Pharmacol | Novel role of NPC1L1 in the regulation of hepatic metabolism: potential contribution of ezetimibe in NAFLD/NASH treatment. | 2011 | Details |
A26154 | 23051943 | Indian J Med Sci | Cryptogenic cirrhosis: metabolic liver disease due to insulin resistance. | 2010 | Details |
A26161 | 20975077 | Exp Biol Med (Maywood) | Digital analysis of hepatic sections in mice accurately quantitates triglycerides and selected properties of lipid droplets. | 2010 | Details |
A26173 | 20960378 | Semin Liver Dis | Novel insights into the pathophysiology of nonalcoholic fatty liver disease. | 2010 | Details |
A26191 | 20936724 | Zhejiang Da Xue Xue Bao Yi Xue Ban | [Effect of sea cucumber cerebroside on lipid metabolism in fatty liver rats]. | 2010 | Details |
A26205 | 20888662 | J Hepatol | Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C. | 2010 | Details |
A26226 | 20868235 | Biol Chem | Bile acid retention and activation of endogenous hepatic farnesoid-X-receptor in the pathogenesis of fatty liver disease in ob/ob-mice. | 2010 | Details |
A26228 | 20865648 | Horm Metab Res | Metabolic parameters and nonalcoholic fatty liver disease in hypopituitary men. | 2010 | Details |
A26243 | 20845385 | Biotechnol J | Hepatoprotective effect of oleuropein in mice: mechanisms uncovered by gene expression profiling. | 2010 | Details |
A26250 | 20840346 | J Eur Acad Dermatol Venereol | Psoriasis and non-alcoholic fatty liver disease. | 2010 | Details |
A26252 | 20836990 | Biochem Biophys Res Commun | Nordihydroguaiaretic acid protects against high-fat diet-induced fatty liver by activating AMP-activated protein kinase in obese mice. | 2010 | Details |
A26254 | 20828853 | J Hepatol | Rosiglitazone promotes fatty acyl CoA accumulation and excessive glycogen storage in livers of mice without adiponectin. | 2010 | Details |
A26276 | 20801629 | J Nutr Biochem | Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice. | 2010 | Details |
A26294 | 20701585 | Curr Diabetes Rev | Interrelationships between hepatic fat and insulin resistance in non-alcoholic fatty liver disease. | 2010 | Details |
A26298 | 20687969 | Br J Nutr | The inhibitory effect of genistein on hepatic steatosis is linked to visceral adipocyte metabolism in mice with diet-induced non-alcoholic fatty liver disease. | 2010 | Details |
A26299 | 20684516 | J Proteome Res | Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease. | 2010 | Details |
A26301 | 20683463 | Eur J Clin Nutr | Intake of n-3 polyunsaturated fatty acids and non-alcoholic fatty liver disease: a cross-sectional study in Japanese men and women. | 2010 | Details |
A26304 | 20675007 | J Hepatol | Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride. | 2010 | Details |
A26305 | 20673376 | Br J Nutr | A polyphenol extract modifies quantity but not quality of liver fatty acid content in high-fat-high-sucrose diet-fed rats: possible implication of the sirtuin pathway. | 2010 | Details |
A26321 | 20653983 | Lipids Health Dis | Preventive effects of chronic exogenous growth hormone levels on diet-induced hepatic steatosis in rats. | 2010 | Details |
A26327 | 20648472 | Hepatology | PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease. | 2010 | Details |
A26329 | 20645852 | Annu Rev Nutr | The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. | 2010 | Details |
A26335 | 20631297 | J Lipid Res | Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2010 | Details |
A26355 | 20602678 | Liver Int | Cannabinoid receptor 1 and 2 agonists increase lipid accumulation in hepatocytes. | 2010 | Details |
A26377 | 20567026 | J Lipid Res | Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats. | 2010 | Details |
A26388 | 20548286 | Lab Invest | Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice. | 2010 | Details |
A26401 | 20513351 | Biochem Biophys Res Commun | Chromium attenuates high-fat diet-induced nonalcoholic fatty liver disease in KK/HlJ mice. | 2010 | Details |
A26405 | 22444262 | Animal | Porcine models for the metabolic syndrome, digestive and bone disorders: a general overview. | 2010 | Details |
A26407 | 20506389 | J Cell Biochem | ERp57 is up-regulated in free fatty acids-induced steatotic L-02 cells and human nonalcoholic fatty livers. | 2010 | Details |
A26418 | 20492324 | J Gastroenterol Hepatol | A fresh look at NASH pathogenesis. Part 1: the metabolic movers. | 2010 | Details |
A26427 | 20473581 | Obes Surg | Hepatic gene networks in morbidly obese patients with nonalcoholic fatty liver disease. | 2010 | Details |
A26428 | 20473151 | Curr Opin Clin Nutr Metab Care | Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammation. | 2010 | Details |
A26434 | 20462650 | J Hepatol | Possible involvement and the mechanisms of excess trans-fatty acid consumption in severe NAFLD in mice. | 2010 | Details |
A26438 | 20460920 | Dig Dis | Genetic and environmental susceptibility to non-alcoholic fatty liver disease. | 2010 | Details |
A26441 | 20460917 | Dig Dis | Molecular mechanisms of hepatic fibrosis in non-alcoholic steatohepatitis. | 2010 | Details |
A26443 | 20460915 | Dig Dis | Bile acids as regulators of hepatic lipid and glucose metabolism. | 2010 | Details |
A26446 | 20460912 | Dig Dis | Liver fat in the pathogenesis of insulin resistance and type 2 diabetes. | 2010 | Details |
A26466 | 20435456 | J Nutr Biochem | Hyperinsulinemia and ectopic fat deposition can develop in the face of hyperadiponectinemia in young obese rats. | 2011 | Details |
A26499 | 20392512 | J Hepatol | Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model. | 2010 | Details |
A26537 | 20303728 | J Nutr Biochem | Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease. | 2010 | Details |
A26546 | 20227267 | Prostaglandins Leukot Essent Fatty Acids | Regulation of hepatic gene expression by saturated fatty acids. | 2010 | Details |
A26548 | 20226139 | Zhong Xi Yi Jie He Xue Bao | [Pathogenesis and treatment of non-alcoholic fatty liver disease]. | 2010 | Details |
A26556 | 20210788 | Basic Clin Pharmacol Toxicol | Hepatic effects of rosiglitazone in rats with the metabolic syndrome. | 2010 | Details |
A26558 | 20206411 | Gastroenterol Hepatol | [Obesity and liver disease]. | 2010 | Details |
A26560 | 20204774 | Adv Exp Med Biol | Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, improves hepatic microcirculatory patency and oxygen availability in a high-fat-diet-induced fatty liver in mice. | 2010 | Details |
A26582 | 20168226 | Curr Opin Gastroenterol | Recent advances in nonalcoholic fatty liver disease. | 2010 | Details |
A26591 | 20143458 | World J Gastroenterol | Is the control of dietary cholesterol intake sufficiently effective to ameliorate nonalcoholic fatty liver disease? | 2010 | Details |
A26601 | 20112035 | Amino Acids | Methionine limitation results in increased hepatic FAS activity, higher liver 18:1 to 18:0 fatty acid ratio and hepatic TAG accumulation in Atlantic salmon, Salmo salar. | 2010 | Details |
A26603 | 20111022 | Obesity (Silver Spring) | Effect of dietary monosodium glutamate on HFCS-induced hepatic steatosis: expression profiles in the liver and visceral fat. | 2010 | Details |
A26612 | 20093562 | Am J Physiol Gastrointest Liver Physiol | The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance. | 2010 | Details |
A26652 | 20041406 | Hepatology | Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. | 2010 | Details |
A26657 | 20036859 | Front Biosci (Elite Ed) | Biochemical characteristics and risk factors in non-alcoholic fatty liver. | 2010 | Details |
A26660 | 20032580 | J Atheroscler Thromb | Expression of perilipin and adipophilin in nonalcoholic fatty liver disease; relevance to oxidative injury and hepatocyte ballooning. | 2009 | Details |
A26670 | 20015565 | J Hepatol | The expression level of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes is highly influenced by hepatic lipid status. | 2009 | Details |
A26709 | 19921118 | Adv Ther | Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status. | 2009 | Details |
A26714 | 19913842 | Metabolism | Analysis of transcriptome and metabolome profiles alterations in fatty liver induced by high-fat diet in rat. | 2009 | Details |
A26737 | 19875987 | Obesity (Silver Spring) | Decreased liver fatty acid delta-6 and delta-5 desaturase activity in obese patients. | 2009 | Details |
A26745 | 19847649 | Dig Dis Sci | The effects of a fat- and sugar-enriched diet and chronic stress on nonalcoholic fatty liver disease in male Wistar rats. | 2009 | Details |
A26753 | 19832698 | Clin Sci (Lond) | Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN. | 2009 | Details |
A26782 | 19793175 | J Gastroenterol Hepatol | Serum ornithine carbamyltransferase reflects hepatic damage in diabetic obese mice. | 2009 | Details |
A26789 | 19781663 | Biochim Biophys Acta | n-3 PUFA and lipotoxicity. | 2009 | Details |
A26790 | 19780876 | J Gastroenterol Hepatol | Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD. | 2009 | Details |
A26791 | 19779336 | Curr Opin Lipidol | Thiazolidinediones and the liver in humans. | 2009 | Details |
A26814 | 19731235 | Hepatology | Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice. | 2009 | Details |
A26820 | 19724016 | Am J Physiol Endocrinol Metab | Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice. | 2009 | Details |
A26837 | 19681867 | Br J Pharmacol | Curcumin adds spice to the debate: lipid metabolism in liver disease. | 2009 | Details |
A26840 | 19673631 | Expert Rev Gastroenterol Hepatol | Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal. | 2009 | Details |
A26857 | 19637730 | Rev Invest Clin | [Pathophysiology of non-alcoholic steatohepatitis. An insulin resistance overview]. | 2009 | Details |
A26871 | 19608932 | J Appl Physiol (1985) | Hepatic VLDL assembly is disturbed in a rat model of nonalcoholic fatty liver disease: is there a role for dietary coenzyme Q? | 2009 | Details |
A26875 | 19602132 | Liver Int | Liver fat and lipid oxidation in humans. | 2009 | Details |
A26880 | 19592219 | Nutrition | Induction of non-alcoholic fatty liver disease and insulin resistance by feeding a high-fat diet in rats: does coenzyme Q monomethyl ether have a modulatory effect? | 2009 | Details |
A26909 | 19556020 | J Hepatol | Second-hand smoke stimulates lipid accumulation in the liver by modulating AMPK and SREBP-1. | 2009 | Details |
A26921 | 19546889 | Cell Res | Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells. | 2009 | Details |
A26958 | 19464748 | J Hepatol | 3,5-diiodo-l-thyronine, by modulating mitochondrial functions, reverses hepatic fat accumulation in rats fed a high-fat diet. | 2009 | Details |
A26966 | 19447517 | J Hepatol | Kupffer cells in non-alcoholic fatty liver disease: the emerging view. | 2009 | Details |
A26989 | 19396962 | Curr Opin Gastroenterol | Recent advances in nonalcoholic fatty liver disease. | 2009 | Details |
A27011 | 19359149 | Nutr Metab Cardiovasc Dis | Hepatic lipid metabolism and non-alcoholic fatty liver disease. | 2009 | Details |
A27042 | 19285022 | Biochem Biophys Res Commun | The hepatic circadian clock is preserved in a lipid-induced mouse model of non-alcoholic steatohepatitis. | 2009 | Details |
A27074 | 19222113 | Am J Chin Med | Therapeutic effect of puerarin on non-alcoholic rat fatty liver by improving leptin signal transduction through JAK2/STAT3 pathways. | 2009 | Details |
A27100 | 19177596 | Hepatology | Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice. | 2009 | Details |
A27117 | 19141695 | Am J Clin Nutr | Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver. | 2009 | Details |
A27135 | 20469672 | Eksp Klin Gastroenterol | [Non-alcoholic fatty liver disease in dyslipidemia and insulin resistance: similarities and differences; differential approach to therapy]. | 2009 | Details |
A27155 | 19072834 | Hepatology | Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist. | 2009 | Details |
A27186 | 19016656 | Clin Sci (Lond) | Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis. | 2008 | Details |
A27199 | 19001666 | J Lipid Res | Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease. | 2008 | Details |
A27203 | 18990087 | Biochem J | Viral hepatitis and fatty liver disease: how an unwelcome guest makes pâté of the host. | 2008 | Details |
A27205 | 18989145 | Eur J Gastroenterol Hepatol | Treatment of preestablished diet-induced fatty liver by oral fatty acid-bile acid conjugates in rodents. | 2008 | Details |
A27223 | 18956291 | Semin Liver Dis | Abnormalities of lipid metabolism in nonalcoholic fatty liver disease. | 2008 | Details |
A27227 | 18949388 | Int J Mol Med | The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease. | 2008 | Details |
A27236 | 18929493 | Trends Endocrinol Metab | Insulin resistance, inflammation, and non-alcoholic fatty liver disease. | 2008 | Details |
A27255 | 18824034 | Prog Lipid Res | Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). | 2008 | Details |
A27288 | 18752326 | Hepatology | Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice. | 2008 | Details |
A27292 | 18719669 | Obesity (Silver Spring) | Effect of endurance exercise on hepatic lipid content, enzymes, and adiposity in men and women. | 2008 | Details |
A27293 | 18713300 | J Gastroenterol Hepatol | Polymorphism of human leptin receptor gene is associated with type 2 diabetic patients complicated with non-alcoholic fatty liver disease in China. | 2008 | Details |